npj Genomic Medicine · 2019 · 46 citations · 36 references
MedicineGeneticsOncologyCancer ScreeningGenetic CounselingMedical GeneticsCancer RiskGenetic Risk AssessmentGermline Cancer PredispositionGermline Cancer SusceptibilityHigh-risk Population IdentificationPopulation ScreeningCascade Genetic TestingGenetic Counseling In Cancer PreventionGenetic Predisposition To CancerGenetic Risk ScreeningGenetic TestingHereditary Cancer RiskPathogenic Variant AssociationUnderrepresented Populations
Abstract Cascade testing for cancer predisposition offers a highly efficient and cost-effective method for identifying individuals at increased risk for cancer, in whom targeted interventions can often improve survival. The aim of this study was to determine the impact of free cascade testing on uptake and identify other associated factors. Demographic and clinical data were gathered prospectively for 183 probands found to have a pathogenic variant associated with cancer predisposition and their 826 first-degree relatives (FDRs). The provision of free cascade testing was significantly associated with uptake (21.6% vs 6.1%; χ 2 , P < 0.001). Relationship type between FDR and proband and FDR age also demonstrated significant associations, suggesting greater engagement amongst younger generations. Overall, 29.0% (53/183) of families had at least 1 FDR who underwent cascade testing. Of these families, 67.9% (36/53) had an uptake rate of at least 40.0%. Cost is a significant barrier to cascade testing uptake in Singapore. Tailored interventions targeting underrepresented groups and genetic counseling approaches supporting family communication and decision-making are necessary.
36
Michelle Landon, Jennifer Saam, Krystal Brown et al. · Oncology · 2015 · 1.9K citations · Full text
Life Sciences, Genetics, Oncology +17
Pathogenic Germline Variants in 10,389 Adult Cancers
Kuan‐lin Huang, R. Jay Mashl, Yige Wu et al. · Cell · 2018 · 888 citations · Full text